What is the current valuation of the embolic protection-devices market in South Korea?

The market valuation was $7.15 Million in 2024. Read More

What is the projected market size for the embolic protection-devices market by 2035?

The market is expected to reach $20.0 Million by 2035. Read More

What is the expected CAGR for the South Korea embolic protection-devices market during 2025 - 2035?

The expected CAGR is 9.8% during the forecast period. Read More

Which companies are the key players in the South Korea embolic protection-devices market?

Key players include Medtronic, Boston Scientific, Abbott Laboratories, and Terumo Corporation. Read More

What are the main types of embolic protection devices available in the market?

The main types include Distal Filter Devices, Distal Occlusion Devices, and Proximal Occlusion Devices. Read More

What is the market valuation for Distal Filter Devices in 2024?

The market valuation for Distal Filter Devices was $2.15 Million in 2024. Read More

How does the usage segment of embolic protection devices break down?

The usage segment includes Disposable Devices valued at $3.5 Million and Re-Usable Devices at $3.65 Million. Read More

What applications are driving the demand for embolic protection devices?

Applications include Cardiovascular Diseases, Coronary Artery Diseases, and Neurovascular Diseases. Read More

What is the market valuation for Nitinol-based embolic protection devices?

The market valuation for Nitinol-based devices was $3.58 Million in 2024. Read More

Which end-users are primarily utilizing embolic protection devices?

End-users include Hospitals & Clinics, Ambulatory Surgical Centers, and Specialty Centers. Read More

South Korea Embolic Protection Devices Market

South Korea Embolic Protection Devices Market Research Report: Size, Share, Trend Analysis By Types (Distal Filter Device, Distal Occlusion Device, Proximal Occlusion Device), By Material (Nitinol, Polyurethane), By Usage (Disposable Device, Reusable Device), By Applications (Cardiovascular Diseases, Neurovascular Diseases, Peripheral Vascular Diseases) and By End Users (Hospitals and Clinics, Ambulatory Surgical Centers, Specialty Centers) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

9.8%

2024 Market Size

$ 7.15 Million

2035 Market Size

$ 20 Million

Healthcare ● Updated April 2026 Report ID: MRFR/HC/52832-HCR | Pages: 200 | Author: Nidhi Mandole, Garvit Vyas

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Chemicals and Materials, BY Type (USD Million)
  1. 4.1.1 Distal Filter Device
  2. 4.1.2 Distal Occlusion Device
  3. 4.1.3 Proximal Occlusion Device
2. 4.2 Chemicals and Materials, BY Material (USD Million)
  1. 4.2.1 Nitinol
  2. 4.2.2 Polyurethane
3. 4.3 Chemicals and Materials, BY Usage (USD Million)
  1. 4.3.1 Disposable Device
  2. 4.3.2 Re-Usable Device
4. 4.4 Chemicals and Materials, BY Application (USD Million)
  1. 4.4.1 Cardiovascular Diseases
  2. 4.4.2 Coronary Artery Diseases
  3. 4.4.3 Trans Catheter Aortic Valve Replacement
  4. 4.4.4 Saphenous Vein Graft Diseases
  5. 4.4.5 Neurovascular Diseases
  6. 4.4.6 Peripheral Vascular Diseases
5. 4.5 Chemicals and Materials, BY End-User (USD Million)
  1. 4.5.1 Hospitals & Clinics
  2. 4.5.2 Ambulatory Surgical Centers
  3. 4.5.3 Specialty Centers
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Chemicals and Materials
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Medtronic (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Boston Scientific (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Abbott Laboratories (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Terumo Corporation (JP)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Cardinal Health (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 B. Braun Melsungen AG (DE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Edwards Lifesciences (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Stryker Corporation (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Asahi Intecc (JP)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 SOUTH KOREA MARKET ANALYSIS BY TYPE
3. 6.3 SOUTH KOREA MARKET ANALYSIS BY MATERIAL
4. 6.4 SOUTH KOREA MARKET ANALYSIS BY USAGE
5. 6.5 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
6. 6.6 SOUTH KOREA MARKET ANALYSIS BY END-USER
7. 6.7 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
8. 6.8 RESEARCH PROCESS OF MRFR
9. 6.9 DRO ANALYSIS OF CHEMICALS AND MATERIALS
10. 6.10 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
11. 6.11 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
12. 6.12 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
13. 6.13 CHEMICALS AND MATERIALS, BY TYPE, 2024 (% SHARE)
14. 6.14 CHEMICALS AND MATERIALS, BY TYPE, 2024 TO 2035 (USD Million)
15. 6.15 CHEMICALS AND MATERIALS, BY MATERIAL, 2024 (% SHARE)
16. 6.16 CHEMICALS AND MATERIALS, BY MATERIAL, 2024 TO 2035 (USD Million)
17. 6.17 CHEMICALS AND MATERIALS, BY USAGE, 2024 (% SHARE)
18. 6.18 CHEMICALS AND MATERIALS, BY USAGE, 2024 TO 2035 (USD Million)
19. 6.19 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 (% SHARE)
20. 6.20 CHEMICALS AND MATERIALS, BY APPLICATION, 2024 TO 2035 (USD Million)
21. 6.21 CHEMICALS AND MATERIALS, BY END-USER, 2024 (% SHARE)
22. 6.22 CHEMICALS AND MATERIALS, BY END-USER, 2024 TO 2035 (USD Million)
23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY MATERIAL, 2025-2035 (USD Million)
  3. 7.2.3 BY USAGE, 2025-2035 (USD Million)
  4. 7.2.4 BY APPLICATION, 2025-2035 (USD Million)
  5. 7.2.5 BY END-USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

South Korea South Korea Embolic Protection Devices Market Segmentation

South Korea Embolic Protection Devices Market By Type (USD Million, 2025-2035)

Distal Filter Device
Distal Occlusion Device
Proximal Occlusion Device

South Korea Embolic Protection Devices Market By Material (USD Million, 2025-2035)

Nitinol
Polyurethane

South Korea Embolic Protection Devices Market By Usage (USD Million, 2025-2035)

Disposable Device
Re-Usable Device

South Korea Embolic Protection Devices Market By Application (USD Million, 2025-2035)

Cardiovascular Diseases
Coronary Artery Diseases
Trans Catheter Aortic Valve Replacement
Saphenous Vein Graft Diseases
Neurovascular Diseases
Peripheral Vascular Diseases

South Korea Embolic Protection Devices Market By End-User (USD Million, 2025-2035)

Hospitals & Clinics
Ambulatory Surgical Centers
Specialty Centers

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”